Evidence map›Paper›PMID 17544285›Full record

ArticleNeurobiology of disease2007

Interleukin 10 and TNFalpha synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia.

Pablo Iribarren, Keqiang Chen, Wanghua Gong, Edward H Cho, Stephen Lockett, Badarch Uranchimeg, Ji Ming Wang

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Microglial Aβ receptors in Alzheimer's disease.Cellular and molecular neurobiology · 2015
    Review
  5. Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  6. Toll-like receptors are key players in neurodegeneration.International immunopharmacology · 2011
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Pablo IribarrenLaboratory of Molecular Immunoregulation, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702, USA. piribarr@mail.fcq.unc.edu.ar
Keqiang Chen
Wanghua Gong
Edward H Cho
Stephen Lockett
Badarch Uranchimeg
Ji Ming Wang
Science Applications International Corporation (United States) · USCenter for Cancer Research · USFrederick National Laboratory for Cancer Research · USNational Cancer Institute · US

Funding

Role of Formylpeptide Receptors in Host DefenseZ01BC010725 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WANG, JI MING · 2006 to 2008
$624k
Role chemoattractant receptors in inflammatory aspects of neurodegenerative DiseZ01BC010723 · NCI · BASIC SCIENCES · PI WANG, JI MING · 2006 to 2007
$160k
NCI NIH HHS N01 CO012400
6 · The paper itself

Abstract

Microglia are important participants in inflammatory responses in the central nervous system. We previously observed that tumor necrosis factor alpha (TNFalpha) induces the expression of the formylpeptide receptor mFPR2 on microglial cells. This chemoattractant receptor mediates microglial cell chemotaxis in response to a variety of peptides, including amyloid beta peptide (Abeta(42)), a major pathogenic factor in Alzheimer's disease (AD). In search for agents that regulate microglial activation, we unexpectedly found that IL-10 enhanced the expression of mFPR2 on TNFalpha-activated microglia. This was associated with a markedly increased microglial chemotaxis to Abeta(42) and its endocytosis via mFPR2. Mechanistic studies revealed that the synergistic effect of IL-10 on TNFalpha-induction of mFPR2 in microglia was dependent on activation of p38 MAPK. Our results suggest that IL-10 may affect the pathogenic process of AD by up-regulating mFPR2 and thus favoring the recognition and internalization of Abeta(42) by activated microglial cells.

Indexed as

Amyloid beta-PeptidesAnimalsCell LineChemotaxisDrug SynergismGene ExpressionHistocompatibility Antigens Class IIInterleukin-10MiceMice, Inbred C57BLMicrogliaNeuroimmunomodulationp38 Mitogen-Activated Protein KinasesPeptide FragmentsReceptors, Formyl PeptideTumor Necrosis Factor-alphaAmyloid beta-Peptidesamyloid beta-protein (1-42)formyl peptide receptor 2, mouseHistocompatibility Antigens Class IIInterleukin-10p38 Mitogen-Activated Protein KinasesPeptide FragmentsReceptors, Formyl PeptideTumor Necrosis Factor-alpha

Identifiers

PMID17544285
PMCPMC1989777
OpenAlexW1976567264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.